Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial

Hugues Chabriat(Université Paris Cité), Usman Khan(SUNY Downstate Health Sciences University), Rohan Grimley(MACOM (United States)), Geoffrey Cloud(Monash University), Laura Dorado, Dirk M. Hermann(University of Duisburg-Essen), Tomasz Berkowicz, P. Bassi(Ospedale San Giuseppe), Klaus Gröschel(Johannes Gutenberg University Mainz), Ute C. Marx(Servier (France)), Stephen M. Davis(The Royal Melbourne Hospital), András Folyovich, Gabriel R. de Freitas(Universidade Federal do Rio de Janeiro), Christian Denier(Inserm), Diederik W.J. Dippel(Erasmus MC), Leonardo Barbarini, Marie-Laure Audoli-Inthavong(Servier (France)), Marianna GOTTSCHAL, Attila Csányi, Jesse Dawson(University of Glasgow), J. Berrouschot, Jae‐Kwan Cha(Dong-A University Hospital), Bernd Kallmuenzer(Friedrich-Alexander-Universität Erlangen-Nürnberg), Hee‐Joon Bae(Seoul National University Bundang Hospital), Aurore Sors(Servier (France)), Anna Członkowska(Institute of Psychiatry and Neurology), Dániel Bereczki(Semmelweis University), Dylan Blacquière(Ottawa Hospital), Katharina Althaus(Christophorus Kliniken), Kenneth Butcher(University of Alberta), Marine Wattez(Servier (France)), Waldemar Brola(Jan Kochanowski University), Claudio L. Bassetti(Swisscom (Switzerland)), Rodrigo Bazán(Universidade Estadual Paulista (Unesp)), Yang‐Ha Hwang(Kyungpook National University Hospital), David Cohen, Charlotte Cordonnier, Hans‐Christoph Diener(Essen University Hospital), Maurício Friedrich(Hospital São Lucas da PUCRS), Martin Grond(Boehringer Ingelheim (Germany)), Waldemar Fryze, Péter Diószeghy(Jósa András Múzeum), Sergi Amaro, Zbigniew Bąk, Philippe Desfontaines, Pere Cardona(Inserm), Hassan Hosseini(Hôpitaux Universitaires Henri-Mondor), Nina De Klippel, Rubens José Gagliardi
The Lancet Neurology
February 18, 2020
Cited by 51


Related Papers